Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
AMT-191 by UniQure for Fabry Disease: Likelihood of Approval
AMT-191 is under clinical development by UniQure and currently in Phase II for Fabry Disease. According to GlobalData, Phase II...